Use of Treatments after Recovery from Thumb Carpometacarpal Arthritis Surgery.

MedStar author(s):
Citation: Plastic & Reconstructive Surgery. 152(2):293e-299e, 2023 Aug 01.PMID: 36912922Institution: Curtis National Hand Center | Curtis National Hand Center | Curtis National Hand Center | Curtis National Hand Center | MedStar Health Research InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Carpometacarpal Joints | *Osteoarthritis | *Plastic Surgery Procedures | *Trapezium Bone | Carpometacarpal Joints/su [Surgery] | Humans | Ligaments/su [Surgery] | Osteoarthritis/su [Surgery] | Thumb/su [Surgery] | Trapezium Bone/su [Surgery]Year: 2023ISSN:
  • 0032-1052
Name of journal: Plastic and reconstructive surgeryAbstract: BACKGROUND: Which treatments patients continue to use more than 1 year after primary thumb carpometacarpal arthritis surgery, and how such use relates to patient-reported outcomes, is largely unknown.CONCLUSIONS: Clinically relevant proportions of patients continue to use various treatments a median of 3 years after primary thumb carpometacarpal arthritis surgery. Continued use of any treatment is associated with significantly worse patient-reported outcomes for function and pain. Copyright © 2023 by the American Society of Plastic Surgeons.METHODS: The authors identified patients who had isolated primary trapeziectomy alone or with ligament reconstruction +/- tendon interposition and were 1 to 4 years postoperative. Participants completed a surgical site-focused electronic questionnaire about what treatments they still used. Patient-reported outcome measures were the Quick Disability of the Arm, Shoulder, and Hand questionnaire and visual analog/numerical rating scales for current pain, pain with activities, and typical worst pain.RESULTS: A total of 112 patients met inclusion and exclusion criteria and participated. At a median of 3 years after surgery, over 40% reported current use of at least one treatment for their thumb carpometacarpal surgical site, with 22% using more than one treatment. Of those who still used treatments, 48% used over-the-counter medications, 34% used home or office-based hand therapy, 29% used splinting, 25% used prescription medications, and 4% used corticosteroid injections. A total of 108 participants completed all patient-reported outcome measures. With bivariate analyses, the authors found that use of any treatment after recovering from surgery was associated with statistically and clinically significantly worse scores for all measures.All authors: Giladi AM, Higgins JP, Means KR Jr, Sanghavi KK, Yousaf ISFiscal year: FY2024Digital Object Identifier: Date added to catalog: 2023-10-04
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 36912922 Available 36912922

BACKGROUND: Which treatments patients continue to use more than 1 year after primary thumb carpometacarpal arthritis surgery, and how such use relates to patient-reported outcomes, is largely unknown.

CONCLUSIONS: Clinically relevant proportions of patients continue to use various treatments a median of 3 years after primary thumb carpometacarpal arthritis surgery. Continued use of any treatment is associated with significantly worse patient-reported outcomes for function and pain. Copyright © 2023 by the American Society of Plastic Surgeons.

METHODS: The authors identified patients who had isolated primary trapeziectomy alone or with ligament reconstruction +/- tendon interposition and were 1 to 4 years postoperative. Participants completed a surgical site-focused electronic questionnaire about what treatments they still used. Patient-reported outcome measures were the Quick Disability of the Arm, Shoulder, and Hand questionnaire and visual analog/numerical rating scales for current pain, pain with activities, and typical worst pain.

RESULTS: A total of 112 patients met inclusion and exclusion criteria and participated. At a median of 3 years after surgery, over 40% reported current use of at least one treatment for their thumb carpometacarpal surgical site, with 22% using more than one treatment. Of those who still used treatments, 48% used over-the-counter medications, 34% used home or office-based hand therapy, 29% used splinting, 25% used prescription medications, and 4% used corticosteroid injections. A total of 108 participants completed all patient-reported outcome measures. With bivariate analyses, the authors found that use of any treatment after recovering from surgery was associated with statistically and clinically significantly worse scores for all measures.

English

Powered by Koha